Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer... ( LAUSANNE Switzerland September 2 ...)

HOME >> MEDICINE >> TECHNOLOGY

Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment

Date:9/2/2008

LAUSANNE, Switzerland, September 2 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, today announced the signature of a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification. The project, named Debio 0826, could lead to the development of potential therapeutic compounds and to the identification of new targets to fight cancer stem cells.

Following the signature of an EPFL-Debiopharm partnership on February 12, this first joint research project will be performed under the supervision of Dr. Freddy Radtke, Associate Professor at the Swiss Institute for Experimental Cancer Research (ISREC) and Dr. Gerardo Turcatti, MER, Director of the Biomolecular Screening Facility (BSF), two groups at the EPFL. Debio 0826 will benefit from the multiple molecular and genetic tools generated by Dr. Radtke's group over the past 10 years, as well as the expertise of Dr. Turcatti in the molecular screening field.

"Targeting pathways controlling cell fate specification could generate innovative anti-cancer drugs with anti-tumoural, anti-metastatic and anti-angiogenic properties to treat tumours that are currently resistant to standard therapies," said Kamel Besseghir, CEO of Debiopharm S.A.

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and
'/>"/>

SOURCE Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

Post Your Comments:

(Date:11/25/2009)...itzerland, Nov. 25 From November ...ive hearing solutions, presented the second editio...ing on the special needs of the older population. ... aging and audiology from around the world and mor... people with hearing loss for an opportunity to sh...

(Date:11/25/2009)...a., Nov. 25 For many of ...ally the 27 million living with untreated hearing...ys audiologist Cindy Beyer. ,, Dr. Beyer, senio...America,s largest hearing care and hearing aids ...o stress, frustration, and social isolation, "whic...

(Date:11/25/2009)... Nov. 25 Regado Biosciences, a pri...ithrombotic aptamers with active control agents, a... will be presenting at the Piper Jaffray 21st Annu...otel in New York City. Dr. Mazzo,s presentation w...1 and will include an overview of the Company,s pi...

Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2 Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3 For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2 For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3 Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2 National All Schedules Prescription Electronic Reporting 28NASPER 29 Act Receives Senate Support 49429 1 National All Schedules Prescription Electronic Reporting 28NASPER 29 Act Receives Senate Support 49429 2 National All Schedules Prescription Electronic Reporting 28NASPER 29 Act Receives Senate Support 49429 3 Statins May Not Protect Against Pneumonia 49427 1 Statins May Not Protect Against Pneumonia 49427 2 American Life League 3A Revelations in Boston Archdiocese Caritas Scandal 49425 1 American Life League 3A Revelations in Boston Archdiocese Caritas Scandal 49425 2 American Life League 3A Revelations in Boston Archdiocese Caritas Scandal 49425 3

[0] Phonak Successfully Hosts Hearing Care for Adults 2009 Conference [0] For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult [0] Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009

...ies: Chromium Picolinate and Chromium Histidinate ...r,s Disease , , Additional Studies Continue to De...romax Chromium Picolinate , , PURCHASE, N.Y., May...eloper and marketer of nutritional supplements und...rands, recently presented results of a research st...

...Pivotal Phase 3 Avanafil Study REVIVE (TA-301) is ...S, Inc. (Nasdaq: VVUS ), a biopharmaceutical com...ies to address unmet needs in obesity, diabetes an...ated an open label safety study (TA-314) with its ...tile dysfunction (ED). , , VIVUS also announced...

Other Medicine Technology:New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings 2 New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings 3 New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings 4 VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction 2 VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction 3

New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction

(Date:11/27/2009)...-SUR-SEINE, France, Nov. 27 Team G...cycling team dedicated to ethical sporting and dev...announced today that it will become Team Garmin-Tr... as a new sponsor of the team. Transitions Optical...yewear, offering the most advanced photochromic te...

(Date:11/27/2009)...7/PRNewswire/-- Allrecipes.com , theworld,s#1food...,withmorethan2.8millionvisitorsthedaybeforeThanksg...ggestfoodholidayoftheyear.TheaverageThanksgivingme...ntincreasefromlastyear,sfeast.AccordingtotheAllrec...ularThanksgivingrecipe,acontrastfromlastyear,spopu...

(Date:11/26/2009)... Nov. 27 With cold and flu season ...ood practices to control the spread of infections ...not only to keep ourselves healthy, but to avoid t...nerty, RN, MS, CIC (certified in infection-control...pational health at Hospital for Special Surgery (H...

(Date:11/26/2009)...ill when on an emotional rollercoaster, study find... -- Call it the fear factor meets the jubilant spo... -- especially those who root for the winning team...ely contested match and victory was in doubt, prod...w on that this Thanksgiving weekend as you,re glue...

(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nati... and Yasmin birth control pills who have suffered ...Stroke, Heart Attack or other related cardiac issu...l toll free at 1-800-856-6405 or go to the firm&rs...l out an online case evaluation form. , ...

Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4 Health News:Watching the Nail-Biting Big Game Hurts So Good 2 Health News:Watching the Nail-Biting Big Game Hurts So Good 3 Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2 Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3

[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use [0] Watching the Nail-Biting Big Game Hurts So Good [0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills

... Guidance for 2009 , , VANCOUVER, Feb. 19 /PRNews...QLT) ("QLT" or the "Company") today reported its f...ember 31, 2008 and full year 2008 as well as issue...us as we concluded a series of corporate developme...

... Feb. 19 /PRNewswire/ - Defyrus Inc. today announc...a patent portfolio created by the United Kingdom,s...and licensed by Ploughshare Innovation Ltd, Dstl,s... Ploughshare Innovation Ltd plan to expand their c...

...ON, Feb. 19 Musculoskeletal Clinical Regulatory A...onsulting firm focused on regulatory, clinical, in...sement strategy development, announced today the s... to date are directly attributed to our best-in-cl...

...uarter Year-Over-Year Highlights: , , - Adjusted ...g amortization], up 19.8% , , - GAAP diluted EPS... , - Net revenues of $24.1 billion , , WOONSOCKET...ear ended December 31, 2008. , , (Logo: http:/...

...es Full-Year 2009 Outlook , , VIRGINIA BEACH, Va....GP ) today announced that its net income for the f...lion, or $0.70 per diluted share, versus net incom...s $50.7 million, or $0.96 per diluted share, inclu...

... Company Offers Free Information K...to its Vulnerability Management and Endpoint Prote...s, Protect Vital Information, and Reduce TCO , ...f its global campaign, "The Lumension Securit...

QLT Announces Fourth Quarter and Year End 2008 Results Vaccine patent portfolio licensed from UK Ministry of Defence Musculoskeletal Clinical Regulatory Advisers, LLC Announces Signing of its 100th Client CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 AMERIGROUP Reports Q4 Net Income of $37.3 Million or $0.70 Per Diluted Share Lumension Unveils Security Stimulus Package to Help Organizations Boost Their Security Posture

...040 Slab Gel Dryer incorporates sturdy metal housi...ving design. The large surface area makes it perfe...le smaller ones., Slim Profile 40cm x 50cm (W x...g Rates allows you to optimize your heating to y...

...r can dry 6 pieces of 10 x 10 cm gel at a time. Th...y several gels at once. It contains optimal sealin...roller controls temperature and timer. The gels ar...e moisture from below to dry the gel homogeneously...

...ly, evenly and safely, the Hoefer GD 2000 uses a d... beneath the gel through a heavy aluminum platen. ... cm in as little as thirty minutes., The heavy alu...ven vacuum distribution under the gel., A clear si...

...ade; gel drying system, 100-120 V, includes Model ...ions. The Model 583 gel dryer is a vacuum-based ge...ariable temperature control and three preprogramme...ed pump used for pulling vacuum on gel dryers requ...

Medicine Products:

Slimline SGD5040 Slab Gel Dryer Midi Gel Dryer GD 2000 Vacuum Gel Dryer System, 115 VAC HydroTech™ Gel Drying System (100-120 V)

Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer...( LAUSANNE Switzerland September 2 ...),Health